Form 4: Caris Life Sciences Executive Gifts Shares

Brian J. Brille, a Director and Vice Chairman at Caris Life Sciences, reported gifting a total of 1,300 shares of common stock.

Summary

• Brian J. Brille, a Director and Vice Chairman and Executive Vice President of Caris Life Sciences, Inc., reported changes in his beneficial ownership of common stock.
• On December 10, 2025, 650 shares of common stock were disposed of through a gift transaction (Transaction Code G) at a price of $0.
• Following this transaction, direct beneficial ownership was 161,778 shares.
• On December 11, 2025, an additional 650 shares of common stock were disposed of through a gift transaction (Transaction Code G) at a price of $0.
• After the second transaction, direct beneficial ownership decreased to 161,128 shares.
• Brille also holds 500,000 shares indirectly through Trusts, with a disclaimer of beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The filing reports a gift of shares by an insider, which is a neutral event in terms of company performance but reduces direct beneficial ownership. It does not indicate a change in company fundamentals.

Negatives

• A reduction of 1,300 shares in direct beneficial ownership by an executive through gift transactions.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minor reduction in direct insider ownership, which could be perceived as a slight decrease in management's direct equity alignment, though the nature of the transaction (gift) mitigates negative interpretations.

Key Dates

Recommendation

The Form 4 reports an insider gifting shares, which is a routine transaction and does not provide sufficient information to alter an investment thesis. It does not reflect a change in company fundamentals or a strategic shift.

Keywords

Caris Life Sciences, CAI, Form 4, Insider Transaction, Stock Gift, Beneficial Ownership, Brian J. Brille